vs

Side-by-side financial comparison of Pathfinder Bancorp, Inc. (PBHC) and Wave Life Sciences Ltd. (WVE). Click either name above to swap in a different company.

Pathfinder Bancorp, Inc. is the larger business by last-quarter revenue ($11.8M vs $8.7M, roughly 1.4× Wave Life Sciences Ltd.). Pathfinder Bancorp, Inc. runs the higher net margin — -52.9% vs -580.2%, a 527.2% gap on every dollar of revenue. On growth, Pathfinder Bancorp, Inc. posted the faster year-over-year revenue change (-22.6% vs -55.8%). Pathfinder Bancorp, Inc. produced more free cash flow last quarter ($10.4M vs $-46.3M). Over the past eight quarters, Pathfinder Bancorp, Inc.'s revenue compounded faster (3.0% CAGR vs -18.0%).

Pathfinder Bancorp, Inc. is a regional bank holding company headquartered in New York, U.S. It operates Pathfinder Bank serving the central New York market, offering retail and commercial banking services including deposit accounts, mortgages, business loans and wealth management for individual consumers and small to medium-sized enterprises.

BIT Life Sciences is a for profit meetings, incentives, conferencing, exhibitions (MICE) company based in Dalian, China, that specializes in arranging multiple scientific congresses that have been described as "predatory". The company is part of a wave of organizations that have appeared in China in the past several years noted for arranging congresses with little academic merit and with the primary aim of generating revenue rather than scientific knowledge sharing. Papers submitted are usual...

PBHC vs WVE — Head-to-Head

Bigger by revenue
PBHC
PBHC
1.4× larger
PBHC
$11.8M
$8.7M
WVE
Growing faster (revenue YoY)
PBHC
PBHC
+33.2% gap
PBHC
-22.6%
-55.8%
WVE
Higher net margin
PBHC
PBHC
527.2% more per $
PBHC
-52.9%
-580.2%
WVE
More free cash flow
PBHC
PBHC
$56.7M more FCF
PBHC
$10.4M
$-46.3M
WVE
Faster 2-yr revenue CAGR
PBHC
PBHC
Annualised
PBHC
3.0%
-18.0%
WVE

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
PBHC
PBHC
WVE
WVE
Revenue
$11.8M
$8.7M
Net Profit
$-5.6M
$-50.5M
Gross Margin
Operating Margin
-81.1%
-606.5%
Net Margin
-52.9%
-580.2%
Revenue YoY
-22.6%
-55.8%
Net Profit YoY
-242.4%
-53.3%
EPS (diluted)
$-0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBHC
PBHC
WVE
WVE
Q4 25
$11.8M
Q3 25
$13.1M
Q2 25
$9.3M
$8.7M
Q1 25
$12.6M
$9.2M
Q4 24
$15.3M
Q3 24
$13.4M
Q2 24
$10.7M
$19.7M
Q1 24
$11.1M
$12.5M
Net Profit
PBHC
PBHC
WVE
WVE
Q4 25
$-5.6M
Q3 25
$626.0K
Q2 25
$31.0K
$-50.5M
Q1 25
$3.0M
$-46.9M
Q4 24
$3.9M
Q3 24
$-4.6M
Q2 24
$2.0M
$-32.9M
Q1 24
$2.1M
$-31.6M
Operating Margin
PBHC
PBHC
WVE
WVE
Q4 25
-81.1%
Q3 25
5.1%
Q2 25
0.4%
-606.5%
Q1 25
29.5%
-542.8%
Q4 24
55.4%
Q3 24
-43.1%
Q2 24
23.3%
-177.7%
Q1 24
24.3%
-274.8%
Net Margin
PBHC
PBHC
WVE
WVE
Q4 25
-52.9%
Q3 25
4.8%
Q2 25
0.3%
-580.2%
Q1 25
23.6%
-510.9%
Q4 24
37.7%
Q3 24
-34.6%
Q2 24
18.7%
-167.2%
Q1 24
19.0%
-251.7%
EPS (diluted)
PBHC
PBHC
WVE
WVE
Q4 25
Q3 25
$0.47
Q2 25
$0.47
$-0.31
Q1 25
$-0.29
Q4 24
Q3 24
$0.41
Q2 24
$0.41
$-0.25
Q1 24
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBHC
PBHC
WVE
WVE
Cash + ST InvestmentsLiquidity on hand
$208.5M
Total DebtLower is stronger
$14.1M
Stockholders' EquityBook value
$122.5M
$139.3M
Total Assets
$1.4B
$252.4M
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBHC
PBHC
WVE
WVE
Q4 25
Q3 25
Q2 25
$208.5M
Q1 25
$243.1M
Q4 24
Q3 24
Q2 24
$154.0M
Q1 24
$180.9M
Total Debt
PBHC
PBHC
WVE
WVE
Q4 25
$14.1M
Q3 25
$18.7M
Q2 25
$21.0M
Q1 25
$17.6M
Q4 24
$27.1M
Q3 24
$39.8M
Q2 24
$45.9M
Q1 24
$45.9M
Stockholders' Equity
PBHC
PBHC
WVE
WVE
Q4 25
$122.5M
Q3 25
$126.3M
Q2 25
$124.4M
$139.3M
Q1 25
$124.9M
$171.8M
Q4 24
$121.5M
Q3 24
$120.2M
Q2 24
$123.3M
$-3.5M
Q1 24
$121.8M
$25.4M
Total Assets
PBHC
PBHC
WVE
WVE
Q4 25
$1.4B
Q3 25
$1.5B
Q2 25
$1.5B
$252.4M
Q1 25
$1.5B
$288.3M
Q4 24
$1.5B
Q3 24
$1.5B
Q2 24
$1.4B
$208.8M
Q1 24
$1.5B
$235.3M
Debt / Equity
PBHC
PBHC
WVE
WVE
Q4 25
0.11×
Q3 25
0.15×
Q2 25
0.17×
Q1 25
0.14×
Q4 24
0.22×
Q3 24
0.33×
Q2 24
0.37×
Q1 24
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBHC
PBHC
WVE
WVE
Operating Cash FlowLast quarter
$11.7M
$-46.0M
Free Cash FlowOCF − Capex
$10.4M
$-46.3M
FCF MarginFCF / Revenue
88.1%
-532.5%
Capex IntensityCapex / Revenue
10.7%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$18.4M
$-170.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBHC
PBHC
WVE
WVE
Q4 25
$11.7M
Q3 25
$7.0M
Q2 25
$-3.7M
$-46.0M
Q1 25
$5.7M
$-63.0M
Q4 24
$11.2M
Q3 24
$11.8M
Q2 24
$1.5M
$-27.5M
Q1 24
$504.0K
$-33.4M
Free Cash Flow
PBHC
PBHC
WVE
WVE
Q4 25
$10.4M
Q3 25
$6.9M
Q2 25
$-4.0M
$-46.3M
Q1 25
$5.1M
$-63.2M
Q4 24
$9.1M
Q3 24
$11.3M
Q2 24
$637.0K
$-27.5M
Q1 24
$274.0K
$-33.8M
FCF Margin
PBHC
PBHC
WVE
WVE
Q4 25
88.1%
Q3 25
52.8%
Q2 25
-42.6%
-532.5%
Q1 25
40.1%
-688.9%
Q4 24
59.9%
Q3 24
84.3%
Q2 24
6.0%
-139.8%
Q1 24
2.5%
-270.0%
Capex Intensity
PBHC
PBHC
WVE
WVE
Q4 25
10.7%
Q3 25
1.0%
Q2 25
2.4%
3.5%
Q1 25
5.1%
1.8%
Q4 24
13.5%
Q3 24
3.8%
Q2 24
8.2%
0.3%
Q1 24
2.1%
3.3%
Cash Conversion
PBHC
PBHC
WVE
WVE
Q4 25
Q3 25
11.26×
Q2 25
-120.55×
Q1 25
1.92×
Q4 24
2.87×
Q3 24
Q2 24
0.76×
Q1 24
0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PBHC
PBHC

Other$5.6M47%
Banking$3.7M31%
Deposit Account$1.5M13%
Financial Service Other$1.0M9%

WVE
WVE

Segment breakdown not available.

Related Comparisons